UNUSUAL CAUSE OF SEVERE ANAEMIA IN A PATIENT WITH METASTATIC HAEMANGIOPERICYTOMA

被引：0

作者：

Vanhaudenarde, V. ^{[1
]}

Duck, L. ^{[2
]}

Mazzeo, F. ^{[1
]}

Graux, C. ^{[3
]}

Jamar, F. ^{[4
]}

Coche, E. ^{[5
]}

Galant, C. ^{[6
]}

Machiels, J. P. ^{[1
]}

机构：

[1] Catholic Univ Louvain, Ctr Canc, Dept Med Oncol, Clin Univ St Luc, B-1200 Brussels, Belgium

[2] Clin St Pierre, Dept Med Oncol, Ottignies, Belgium

[3] Catholic Univ Louvain, Dept Hematol, CHU Mt Godinne, Yvoir, Belgium

[4] Catholic Univ Louvain, Dept Nucl Med, Clin Univ St Luc, B-1200 Brussels, Belgium

[5] Catholic Univ Louvain, Dept Med Imaging, Clin Univ St Luc, B-1200 Brussels, Belgium

[6] Catholic Univ Louvain, Dept Pathol, Clin Univ St Luc, B-1200 Brussels, Belgium

来源：

ACTA CLINICA BELGICA | 2013年 / 68卷 / 02期

关键词：

Haemangiopericytoma; anaemia; haemorrhages; spleen metastases; EGFR TKi; FIBROUS TUMOR; PHASE-II;

D O I：

10.2143/ACB.3219

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Haemangiopericytoma is a rare tumor of vascular origin. We report the case of patient with severe refractory anaemia due to peripheral destruction of red blood cells by spleen metastases. Anaemia was successfully treated by splenectomy. Afterwards, our patient developed liver and lung metastases and was treated, in a clinical trial, with gefitinib that stabilised the disease during nine years. These interesting features are discussed.

引用

页码：120 / 123

页数：4

共 14 条

[1] Drews RE, 2011, UPTODATE
[2] HEMANGIOPERICYTOMA - ANALYSIS OF 106 CASES
ENZINGER, FM
SMITH, BH
[J]. HUMAN PATHOLOGY, 1976, 7 (01) : 61 - 82
[3] Conventional hemangiopericytoma modern analysis of outcome - Modern analysis of outcome
Espat, NJ
Lewis, JJ
Leung, D
Woodruff, JM
Antonescu, CR
Shia, J
Brennan, MF
[J]. CANCER, 2002, 95 (08) : 1746 - 1751
[4] Solitary fibrous tumour and haemangiopericytoma: evolution of a concept
Gengler, C
Guillou, L
[J]. HISTOPATHOLOGY, 2006, 48 (01) : 63 - 74
[5] George S, 2012, UPTODATE
[6] Cytogenetic abnormalities in a hemangiopericytoma of the spleen
Hallén, M
Parada, LA
Gorunova, L
Pålsson, B
Dictor, M
Johansson, B
[J]. CANCER GENETICS AND CYTOGENETICS, 2002, 136 (01) : 62 - 65
[7] Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Maki, Robert G.
D'Adamo, David R.
Keohan, Mary L.
Saulle, Michael
Schuetze, Scott M.
Undevia, Samir D.
Livingston, Michael B.
Cooney, Matthew M.
Hensley, Martee L.
Mita, Monica M.
Takimoto, Chris H.
Kraft, Andrew S.
Elias, Anthony D.
Brockstein, Bruce
Blachere, Nathalie E.
Edgar, Mark A.
Schwartz, Lawrence H.
Qin, Li-Xuan
Antonescu, Cristina R.
Schwartz, Gary K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3133 - 3140
[8] Marec-Berard P, 2003, ORPHANET
[9] Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor
Park, Min S.
Ravi, Vinod
Araujo, Dejka M.
[J]. CURRENT OPINION IN ONCOLOGY, 2010, 22 (04) : 351 - 355
[10] New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors
Park, Min S.
Araujo, Dejka M.
[J]. CURRENT OPINION IN ONCOLOGY, 2009, 21 (04) : 327 - 331

← 1 2 →